National Instruments Reports Record Quarterly Revenue

When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company’s operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related transaction costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held-for-sale, gain on divestment, and capitalization and amortization of internally developed software costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods; to establish operational goals; to compare with its business plan and individual operating budgets; to measure management performance for the purposes of executive compensation, including payments to be made under bonus plans; to assist the public in measuring the company’s performance relative to the company’s long-term public performance goals; to allocate resources; and, relative to the company’s historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.

This news release discloses the company’s EBITDA for the three-month and 12-month periods ending Dec. 31, 2019 and 2018. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this news release.

Forward-Looking Statements

This release contains “forward-looking statements” including statements regarding that this is a reflection of our realignment, execution to our strategy and commitment to operational excellence, believing we are entering 2020 with renewed momentum, remaining confident in the continued success of NI under Eric, our highly capable new CEO, belief that we are in a stronger position than ever, that we have created a solid foundation which we believe will help accelerate our growth and achieve our long-term aspirations for all our stakeholders, belief that our strong results show the stability provided by our broad customer base and end-market diversity, the value customers see in our innovative platform, and our ability to scale, expecting Q1 revenue to be in the range of $308 million to $338 million, expecting that GAAP diluted EPS will be in the range of $0.99 to $1.13 for Q1, with non-GAAP diluted EPS expected to be in the range of $0.24 to $0.38; estimating its non-GAAP effective tax rate to be approximately 17% to 18% percent for 2020; expecting that for a significant majority of software development projects the costs incurred subsequent to the achievement of technological feasibility will be immaterial in future periods; expecting to record significantly less capitalized software development costs than under its historical software development approaches; and expecting amortization of previously capitalized software development costs to steadily decline as previously capitalized software development costs become fully amortized over the next four years. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, further adverse fluctuations in our industry, foreign exchange fluctuations, changes in the current global trade regulatory environment, fluctuations in demand for NI products including orders from NI’s large customers, component shortages, delays in the release of new products, the company’s ability to effectively manage its operating expenses, manufacturing inefficiencies and the level of capacity utilization, the impact of any recent or future acquisitions or divestitures by NI, expense overruns, disruption from public health concerns and adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results.

The company directs readers to its Form 10-K for the year ended Dec. 31, 2018, its Form 10-Q for the quarter ended Sept. 30, 2019 and the other documents it files with the SEC for other risks associated with the company’s future performance.

About NI

NI ( www.ni.com) empowers engineers and scientists with a software-centric platform that incorporates modular hardware and an expansive ecosystem. This proven approach puts users firmly in control of defining what they need to accelerate their system design within test, measurement and control. NI’s solution helps build high-performance systems that exceed requirements, quickly adapt to change and ultimately improve the world. (NATI-F)

National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.

 

National Instruments

Condensed Consolidated Balance Sheets

(in thousands)

 

December 31,

 

December 31,

 

2019

 

2018

 

(unaudited)

 

 

ASSETS

 

 

Current assets:

 

 

Cash and cash equivalents

194,616

 

259,386

 

Short-term investments

237,983

 

271,396

 

Accounts receivable, net

248,872

 

242,955

 

Inventories, net

200,410

 

194,146

 

Prepaid expenses and other current assets

65,477

 

54,337

 

Total current assets

947,358

 

1,022,220

 

 

 

 

Property and equipment, net

243,717

 

245,201

 

Goodwill

262,242

 

264,530

 

Intangible assets, net

84,083

 

110,783

 

Operating lease right-of-use assets

70,407

 

 

Other long-term assets

44,082

 

28,501

 

Total assets

1,651,889

 

1,671,235

 

 

 

 

LIABILITIES AND EQUITY

 

 

Current liabilities:

 

 

Accounts payable and accrued liabilities

52,192

 

48,388

 

Accrued compensation

47,732

 

45,821

 

Deferred revenue - current

131,445

 

127,288

 

Other lease liabilities - current

13,431

 

 

Other taxes payable

40,607

 

35,574

 

Other current liabilities

20,716

 

25,913

 

Total current liabilities

306,123

 

282,984

 

 

 

 

Deferred income taxes

14,065

 

25,457

 

Liability for uncertain tax positions

6,652

 

9,775

 

Income tax payable - long-term

69,151

 

74,546

 

Deferred revenue - long-term

33,480

 

32,636

 

Operating lease liabilities - non-current

40,650

 

 

Other long-term liabilities

5,418

 

7,479

 

Total liabilities

475,539

 

432,877

 

 

 

 

Stockholders' equity:

 

 

Preferred stock

 

 

Common stock

1,305

 

1,327

 

Additional paid-in capital

953,578

 

897,544

 

Retained earnings

242,537

 

356,418

 

Accumulated other comprehensive loss

(21,070

)

(16,931

)

Total stockholders' equity

1,176,350

 

1,238,358

 

Total liabilities and stockholders' equity

1,651,889

 

1,671,235

 

 

National Instruments

Condensed Consolidated Statements of Income

(in thousands, except per share data, unaudited)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Years Ended

 

 

December 31,

 

December 31,

 

 

2019

 

2018

 

2019

 

2018

 

 

 

 

 

 

Net sales:

 

 

 

 

 

Product

$

332,267

 

$

322,672

 

 

$

1,215,014

 

$

1,220,027

 

Software maintenance

35,201

 

37,427

 

 

138,201

 

139,105

 

Total net sales

367,468

 

360,099

 

 

1,353,215

 

1,359,132

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

Product

89,308

 

86,003

 

 

329,364

 

325,208

 

Software maintenance

1,827

 

2,026

 

 

7,527

 

8,519

 

Total cost of sales

91,135

 

88,029

 

 

336,891

 

333,727

 

 

 

 

 

 

 

Gross profit

276,333

 

272,070

 

 

1,016,324

 

1,025,405

 

 

75%

76%

 

75%

75%

Operating expenses:

 

 

 

 

 

Sales and marketing

121,052

 

117,102

 

 

473,392

 

482,576

 

Research and development

71,471

 

66,151

 

 

272,452

 

261,072

 

General and administrative

30,129

 

26,996

 

 

122,768

 

108,878

 

Gain on sale of asset

 

 

 

(26,842

)

 

Total operating expenses

222,652

 

210,249

 

 

841,770

 

852,526

 

 

 

 

 

 

 

Operating income

53,681

 

61,821

 

 

174,554

 

172,879

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

Interest income

1,942

 

2,051

 

 

8,129

 

5,896

 

Net foreign exchange (loss) gain

(223

)

(1,341

)

 

(1,846

)

(3,423

)

Other (loss) income, net

(1,108

)

932

 

 

(293

)

1,101

 

 

 

 

 

 

 

Income before income taxes

54,292

 

63,463

 

 

180,544

 

176,453

 

 

 

 

 

 

 

(Benefit) Provision for income taxes

(4,304

)

6,922

 

 

18,393

 

21,396

 

 

 

 

 

 

 

Net income

$

58,596

 

$

56,541

 

 

$

162,151

 

$

155,057

 

 

 

 

 

 

 

Basic earnings per share

$

0.45

 

$

0.43

 

 

$

1.23

 

$

1.17

 

Diluted earnings per share

$

0.45

 

$

0.42

 

 

$

1.22

 

$

1.16

 

 

 

 

 

 

 

Weighted average shares outstanding -

 

 

 

 

 

Basic

130,776

 

132,565

 

 

131,722

 

131,987

 

Diluted

131,432

 

133,617

 

 

132,734

 

133,274

 

 

 

 

 

 

 

Dividends declared per share

$

0.25

 

$

0.23

 

 

$

1.00

 

$

0.92

 

 

National Instruments

Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

Years Ended December 31,

 

 

2019

 

2018

 

(unaudited)

 

Cash flow from operating activities:

 

 

Net income

$

162,151

 

$

155,057

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

Depreciation and amortization

73,541

 

70,667

 

Stock-based compensation

51,438

 

37,616

 

Disposal gain on sale of asset

(26,842

)

 

Tax benefit from deferred income taxes

(12,680

)

(11,738

)

Net change in operating assets and liabilities

(23,203

)

22,978

 

Net cash provided by operating activities

224,405

 

274,580

 

 

 

 

Cash flow from investing activities:

 

 

Purchases of property, plant, and equipment

(60,857

)

(34,659

)

Proceeds from sale of office building

32,492

 

 

Capitalization of internally developed software

(9,065

)

(14,208

)

Additions to other intangibles

(1,209

)

(5,399

)

Acquisitions of equity-method investments

(13,670

)

 

Acquisitions, net of cash received

 

(5,534

)

Purchases of short-term investments

(185,267

)

(313,726

)

Sales and maturities of short-term investments

219,628

 

163,530

 

Net cash used by investing activities

(17,948

)

(209,996

)

 

 

 

Cash flow from financing activities:

 

 

Proceeds from issuance of common stock

33,191

 

31,601

 

Repurchase of common stock

(171,316

)

 

Dividends paid

(131,855

)

(121,537

)

Other

(837

)

(907

)

Net cash used by financing activities

(270,817

)

(90,843

)

 

 

 

Impact of changes in exchange rates on cash

(410

)

(4,519

)

 

 

 

Net change in cash and cash equivalents

(64,770

)

(30,778

)

Cash and cash equivalents at beginning of period

259,386

 

290,164

 

Cash and cash equivalents at end of period

$

194,616

 

$

259,386

 


« Previous Page 1 | 2 | 3 | 4  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise